Acasă › Cancer ovarian › Georgia › Atlanta
Studii clinice pentru Cancer ovarian în Atlanta, GA
29 studii pentru Cancer ovarian caută participanți în și în jurul orașului Atlanta (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
În curs de recrutareFaza 2/3
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Winship Cancer Institute of Emory University, Atlanta
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
În curs de recrutareFaza 1
- Emory University, Atlanta
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- Emory Winship Cancer Institute, Atlanta
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
În curs de recrutareStudiu observațional
- Piedmont Healthcare, Atlanta
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
În curs de recrutareFaza 2
- Site 0108 - Emory University Hospital, Atlanta
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
În curs de recrutareFaza 3
- Winship Cancer Institute, Emory University, Atlanta
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
În curs de recrutareFaza 3
- Winship Cancer Institute of Emory University ( Site 0037), Atlanta
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
În curs de recrutareFaza 3
- Winship Cancer Institute At Emory University, Atlanta
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
În curs de recrutareFaza 1/2
- Emory University, Atlanta
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
În curs de recrutareFaza 1
- Emory University, Atlanta
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
În curs de recrutareFaza 3
- Winship Cancer Institute of Emory University ( Site 0086), Atlanta
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
În curs de recrutareFaza 2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
În curs de recrutareFaza 1
- Emory University - Winship Cancer Institute, Atlanta
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
În curs de recrutareFaza 3
- Emory University, Atlanta
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Winship Cancer Institute, Emory University, Atlanta
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
În curs de recrutareFaza 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
În curs de recrutare
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- și încă 3
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
În curs de recrutareFaza 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- și încă 3
Clinical Pre-screening Protocol for Ovarian Cancer
În curs de recrutareStudiu observațional
- Emory Winship Cancer Institute, Atlanta
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Winship Cancer Institute, Emory University, Atlanta
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
În curs de recrutareFaza 1/2
- Winship Cancer Institute, Emory University, Atlanta
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
În curs de recrutareFaza 2
- GSK Investigational Site, Atlanta
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
În curs de recrutareVoluntari sănătoși bineveniți
- Emory University Hospital/Winship Cancer Institute, Atlanta
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 2
- USA10-0, Atlanta
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
În curs de recrutareFaza 1/2
- Emory Winship Cancer Institute, Atlanta
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
În curs de recrutareFaza 2
- Winship Cancer Institute, Emory University, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
În curs de recrutareFaza 1/2
- Emory - Winship Cancer Institute, Atlanta
Studii pentru Cancer ovarian în alte orașe
- Houston, TX89 studii
- New York City, NY69 studii
- Boston, MA61 studii
- Los Angeles, CA50 studii
- Nashville, TN49 studii
- Arlington, VA46 studii
- Philadelphia, PA44 studii
- Columbus, OH39 studii
- St. Louis, MO38 studii
- Chicago, IL36 studii
- San Antonio, TX31 studii
- Cleveland, OH30 studii
Alte studii în Atlanta
- Cancer (toate tipurile)49 studii
- Cancer pulmonar cu celule non-pătrate47 studii
- Mielom multiplu42 studii
- Cancer de sân41 studii
- Cancer de prostată33 studii
- Leucemie mieloasă acută31 studii
- Cancer colorectal29 studii
- Cancer pulmonar29 studii
- Cancer metastatic28 studii
- Tulburare depresivă majoră25 studii
- Insuficiență cardiacă25 studii
- Carcinom cu celule scuamoase de cap și gât24 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.